Probability of organ confined disease in men with prostate cancer
The current composite model combines multiple risk prediction models that all calculate the probability of organ confined prostate cancer. 
Details Files & References
Composite
Model author
Version
1.7
Revision date
2018-04-30
Specialty
MeSH terms
  • Prostate Cancer
  • Status
    public
    Share

    ...

    {{ resultSubheader }}

    {{ model.survival.PITTitle }}

    {{ model.survival.YNETitle }}

    Results
    Note
    Notes are only visible in the result download and will not be saved by Evidencio

    Composite model

    Conditional information

    Result interpretation

    {{ file.classification }}

    Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

    Comments
    Rating
    Comment
    Please enter a comment of rating
    Comments are visible to anyone

    Model feedback

    No feedback yet 1 Comment {{ model.comments.length }} Comments
    Not rated | On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
    {{ comment.content }}
    Underlying models
    MSKCC Nomogram: Probability of organ-confined disease in prostate cancer patients (includes biopsy cores)
    Research authors: Source: Memorial Sloan Kettering Cancer Center (US)
    Partin Tables update 2013: Organ confined disease
    Research authors: John B. Eifler, Zhaoyang Feng, Brian M. Lin, Michael T. Partin, Elizabeth B. Humphreys, Misop Han, Jonathan I. Epstein, Patrick C. Walsh, Bruce J. Trock, Alan W. Partin
    Partin Tables update 2007: Organ confined disease
    Research authors: Danil V. Makarov, Bruce J. Trock, Elizabeth B. Humphreys, Leslie A. Mangold, Patrick C. Walsh, Jonathan I. Epstein, Alan W. Partin
    Partin Tables update 2016: Organ confined disease
    Research authors: Jeffrey T. Tosoian, Meera Chappidi, Zhaoyong Feng, Elizabeth B. Humphreys, Misop Han, Christian P. Pavlovich, Jonathan I. Epstein, Alan W. Partin, Bruce J. Trock